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Abstract: Background: Desmoplastic fibroma (DF) is an extremely rare locally aggressive bone tumor with an incidence 
of 0.11% of all primary bone tumors. The typical clinical presentation is pain and swelling above the affected area. The 
most common sites of involvement are the mandible and the metaphysis of long bones. Histologically and biologically, 
desmoplastic fibroma mimics extra-abdominal desmoid tumor of soft tissue. 
Case Presentation and Literature Review: A case of a 27-year old man with DF in the ilium, including the clinical, 
radiological and histological findings over a 4-year period is presented here. CT scans performed in 3-year intervals prior 
to surgical intervention were compared with respect to tumor extension and cortical breakthrough. The patient was treated 
with curettage and grafting based on anatomical considerations. Follow-up CT scans over 18-months are also documented 
here. Additionally, a review and analysis of 271 cases including the presented case with particular emphasis on imaging 
patterns in MRI and CT as well as treatment modalities and outcomes are presented. 
Conclusion: In patients with desmoplastic fibroma, CT is the preferred imaging technique for both the diagnosis of 
intraosseus tumor extension and assessment of cortical involvement, whereas MRI is favored for the assessment of 
extraosseus tumor growth and preoperative planning. While tumor resection remains the preferred treatment for DF, 
curettage and grafting prove to be an acceptable alternative treatment modality with close follow-up when resection is not 
possible. Curettage and grafting have been shown to provide good clinical results and are associated with long recurrence 
free intervals. 
Keywords: Desmoplastic fibroma, rare bone tumor, benign bone tumor, curettage, autograft, review. 
1. INTRODUCTION 
 Desmoplastic fibroma (DF) is a benign intraosseus 
neoplasia with locally aggressive and infiltrative 
characteristics. DF was first described by Jaffe in 1958 [1]. 
In 2002 DF was defined by the WHO as a rare benign bone 
tumor composed of spindle-shaped cells with minimal 
cytological atypia and abundant collagen production [2]. DF 
represents one of the most uncommon bone diseases as it has 
an incidence of only 0.11% of all primary bone tumors [3]. 
While the potential for malignant transformation in DF has 
been mentioned, it has not been reported in cases [4]. 
 In 1996 Böhm et al. [5] reviewed 184 published cases of 
DF and in a metaanalysis reported the mean age of DF 
patients at the time of diagnosis as 23 years with a range 
from 15 months to 75 years. Sex predilection remains 
unclear while some authors report higher rates of DF in 
female patients [6] and others report no detectable sex 
predilection [7]. DF can theoretically affect any bone, but the 
majority of cases occur in the mandible (22%) and the 
metaphysis of long bones (56%) [8]. The pelvis accounts for 
12% of cases. To the best of our knowledge 15 cases of DF 
in the iliac bone have been reported to date. 
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 The clinical presentation of DF is non-specific and 
usually presents as pain over the affected area and 
occasionally as a palpable mass. DF has also been detected 
incidentally [9]. On a plain radiograph DF is not always 
easily differentiated from other benign or malignant tumors. 
 Because DF has a recurrence rate of 37% to 72% [5, 10], 
resection of the affected bone is the preferred therapy, and 
ideally an en bloc resection [11]. Cases in which anatomical 
considerations limit resection, alternative therapy has been 
curettage and reported to achieve recurrence free survival up 
to 9 years [12]. The average rate of recurrence after curettage 
has been reported to be 55% [5]. The imaging features of DF 
have been characterized in a few studies [11, 13] but to our 
knowledge no study has been published that presents the 
cross-section radiographic patterns and development of DF 
over a time period of three years. 
 This study presents the case of a 27-year old man, who 
complained of increasing pain in the sacroiliac joint for over 
3 years. The patient has given informed consent for 
publication of his case. 
2. CASE PRESENTATION 
 A 27-year old man presented to our outpatient 
department with increasing pain in the region of the right 
sacroiliac joint. The pain started three years earlier, at which 
point the patient sought help from a local orthopaedic 
surgeon. At this initial presentation it was thought that his 
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pain was attributable to his physically demanding job. A CT-
scan and MRI-scan were performed and revealed a bone cyst 
with sclerotic borders without destruction of the cortical 
bone (Figs. 1, 2). Signs of malignancy were not present. 
Accordingly, the patient was treated with physical therapy, 
chiropractic treatment, and pain control. 
 
Fig. (1). CT-scan three years preoperative. The corticalis is 
preserved. Within the lesion pseudo-trabeculation is visible. 
 
Fig. (2). T1-weighted MRI three years preoperative. Note that the 
lesion presents with low signal intensity and no infiltration of the 
surrounding tissue. 
 Over time his pain increased to the point of requiring 
opioids for pain control and presenting to our hospital. In the 
interim, he changed his job and decreased his physical 
activity, neither of which alleviated his pain. 
 On physical examination the patient had tenderness to 
palpation and vibration over his right sacroiliac joint. 
Peripheral motor and sensory functions were intact, no 
pathologic reflexes were present. The patient was in a good 
general state of health. A CT-scan was repeated and showed 
a slightly enlarged bone cyst compared to the previous CT-
scan three years ago. However, no cortical breakthrough was 
present (Fig. 3). 
 For further diagnostic workup an open biopsy of the 
lesion was performed one week later. The histological 
examination of the tissue demonstrated the formation of 
abundant collagen fibers and spindle shaped cells with 
medium to low cell density. The nuclei were without 
pleomorphism and mitotic activity. In immuno-staining the 
nuclei of the tumor cells were positively labeled for the 
adhesion protein -catenin. In addition there was a partially 
positive staining recognized for S-100. Morphology and 
immunophenotype were consistent with either aggressive 
fibromatosis or desmoplastic fibroma, both of which express 
-catenin (Fig. 4). Because of its intraosseus location the 
working diagnosis of desmoplastic fibroma was made. 
Accordingly the indication for operative excision via 
curettage and grafting was established. 
 The operation was performed with the patient under 
general anaesthesia. The tumor was removed in several parts. 
The tissue was beige in color with hard and soft areas of 
consistency (Fig. 5). The removed tumor was sent for further 
histological examination to the department of pathology. 
 The lesion was filled with autologous bone graft from the 
iliac crest that was mixed with Cerasorb
®
 (Curasan, 
Kleinostheim, Germany) and blood from the patient. 
Operating time was 105 minutes. After surgery the patient 
was restricted to no weight bearing on the operated side until 
complete wound healing. Compared to a more invasive 
treatment option, this therapeutic approach has the advantage 
of reduced operating time and earlier recovery. 
 No postoperative radiation of the lesion was performed to 
enable adequate integration of the bone graft. 
 Histological workup of the removed tissue demonstrated 
the identical picture as the biopsy and accordingly no signs 
of malignancy. 
 Postoperative follow-up examinations as well as CT-
scans 6 and 18 months after surgery showed good integration 
of the graft (Figs. 6, 7). There were no signs of recurrence. 
3. DISCUSSION 
 This case represents a typical presentation of desmoplastic 
fibroma clinically, radiographically and histologically. 
 
Fig. (3). CT-scan 2 weeks before the operation. There is cortical breakthrough of the tumor. The size of the lesion has slightly increased in 
comparison the previous CT-scan. 
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Fig. (5). Intraoperative photograph showing the removed tissue. It 
has a beige color and hard as well as soft areas of consistency. 
 Desmoplastic fibroma is a very rare bone tumor, 
affecting the mandible, long bones, and pelvis. 
Morphologically a distinction between desmoplastic fibroma 
and aggressive fibromatosis is not possible. Aggressive 
fibromatosis, also called desmoid tumor, was described 
before desmoplastic fibroma and is defined as rare 
mesenchymal neoplasia composed of collagenous tissue and  
 
 
Fig. (6). CT-scan 6 months after the operation. No residual tumor is 
present. 
spindle-shaped cells [14]. Desmoid tumors can be localized 
intraabdominally, within the abdominal wall and also 
extraabdominally. Most desmoid tumors are abdominal (to 
69%) [14]. The intraosseus variant is the desmoplastic 
fibroma. 
 The characteristics of DF in MR and CT imaging have 
been well described in a case report by Stefanidis et al. [11]. 
The tumor reported in this case was an osteolytic lesion with 
destruction of the cortical bone, minor pseudotrabeculation, 
and marginal sclerosis. In T1-weighted sequences the tumor 
showed low signal intensity with signal enhancement after  
 
  
HE stain (20x magnification) -Catenin stain (20x magnification) 
  
S100-stain (20x magnification) Ki67 stain (20x magnification) 
Fig. (4). Histological examination of biopsy shows abundant collagen fibers, strong positive labelling for the adhesion protein -Catenin, 
weak positive labelling for S-100 and almost no positive stain for the proliferation marker Ki67. 
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contrast agent administration. These findings were also 
present in our case. The initial CT scan three years prior to 
surgery shows an osteolytic lesion with marginal sclerosis 
and slight pseudotrabeculation. A cortical breakthrough was 
not present initially. In both T2-weighted and contrast 
enhanced T1 SPIR sequences the tumor exhibited high signal 
intensity. 
 
Fig. (7). CT-scan 18 months after the operation. The bone graft is 
well integrated in pelvic bone. No discontinuity of the cortical 
bone. No recurrence of the tumor is present. 
 The preoperative CT-scans showed increased tumor size 
compared to initial scans three years prior with cortical 
breakthrough in several areas, indicating bone instability. An 
isolated extraosseus growth was not present at any time. 
 Crim et al. [15], who analyzed the radiographic 
characteristics of DF in 83 patients from case reports, 
reported that only in 29% of patients cortical breakthrough 
was present. If cortical damage is suspected a CT-scan 
should be performed to better visualize the bone structure 
and to quantify cortical bone destruction. 
 If extraosseus tumor growth is suspected a MRI is 
preferred. MR-scans are also helpful for preoperative 
planning as the extent of the tumor and its relation to 
anatomical landmarks can be evaluated. 
 The diagnosis of DF is difficult by imaging studies alone. 
In both MR and CT imaging, many tumors resemble imaging 
of DF. These tumors are: fibrous dysplasia, giant cell tumor, 
simple bone cyst, aneurysmatic bone cyst, 
chondromyxofibroma, non-ossifying fibroma, eosinophilic 
granuloma, adamantinoma, and metastases. 
 The histological picture of DF is dominated by abundant 
collagen fibers and low density of cells. The nuclei are long 
and spindle shaped. Signs of mitosis are usually not present. 
The histological differential diagnosis includes the spindle 
cell tumors and tumor like lesions, including juvenile bone 
cyst and aneurysmatic bone cyst. The most important 
histological differential diagnosis is low-grade fibrosarcoma. 
Fibrosarcoma typically presents with high cell density, high 
grade of polymorphism, and a high rate of mitosis. In rare 
cases of low-grade fibrosarcoma mitotic activity is not 
present and the tissue is collagen rich with a low cell count, 
such that differentiation between desmoplastic fibroma and 
fibrosarcoma is not possible. In these cases the postoperative 
clinical development helps to establish the definite diagnosis. 
 For further diagnostical workup several 
immunohistochemical biomarkers are applicable to narrow 
down the differential diagnosis. In the presented case the 
tumor stained highly positive for -catenin (Table 1), which 
is in accordance with the results of Hauben et al. [16], who 
examined the significance of -catenin expression in DF in 
comparison to aggressive fibromatosis. In aggressive 
fibromatis -catenin is sporadically associated with familial 
adenomatous polyposis coli (FAP) by a shared APC/ -
catenin pathway. This link however is not present in 
desmoplastic fibroma. 
 In this presented case the patient was treated with 
curettage and grafting. Given that DF has a recurrence rate of 
up to 72% after non-resection procedures (e.g. curettage) and 
17% after resection (Table 2), the literature advocates 
resection (marginal or wide) as the treatment of choice [5]. 
Alternatively Nishida et al. [12] reported about 5 cases that 
were treated with curettage and did not show any sign of 
recurrence for the follow-up period of 5.5 to 9 years. In 2 of 
Table 1. Immunhistochemical Marker Used to Narrow Down the Differential Diagnosis 
 
Antigen Present Patient Interpretation 
-Catenin ++ up regulated in desmoplastic fibroma [16] and aggressive fibromatosis [17] 
S-100 + ubiquitary present protein (glia cells, adipocytes, melancytes, chondrocytes) 
actin (+) nucleus ubiquitary present protein (mainly myocytes). Together with Desmin up regulated in leiomyosarcoma  
KiM1P (+) nucleus present in histiocytes 
MDM 2 (+) nucleus Together with MDM 2 and CDK4 upregulated in liposarcoma 
CD31/CD34 - up regulated in angiogenesis 
MyoD1 - up regulated in rhabdomysarcoma 
myogenin - up regulated in rhabdomysarcoma 
desmin - up regulated in leiomysarcoma 
CDK4 - up regulated in liposarcoma 
DOG1 - up regulated in GIST 
Ki67 positive in 2% of cells up regulated in proliferating cells 
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the 5 patients the pelvis was affected by DF. Similar to those 
cases, no isolated extraosseus growth of tumor was present 
in our case. This characteristic along with slow tumor 
growth, documented by CT-scans for 3 years, were 
determining factors to keep the surgical therapy as less 
invasive as possible. 
 In 2011, a case was published by Stefanidis et al. [11], 
reporting the clinical and radiographic development of DF 
located in the ilium with a follow-up period of 6 years. The 
tumor was removed by curettage and replaced by bone graft. 
The patient was free of recurrence for 6 years. 
 Another case of DF in the ilium by Gebhardt et al. [10] 
was reported with a wider extension of tumor growth and 
involved the acetabulum, pubic bone and ischium. This was 
also a case of extraosseus tumor expansion. Isolated 
extraosseus filiae, however, were not present. The treatment 
Table 2. Treatment of DF and Corresponding Rate of Recurrence 
 
Primary Therapy Number of Cases Number of Recurrences Percentage of Recurrence 
Biopsy 3 2 66% 
Curettage 52 27 52% 
Curettage and radiotherapy 2 0 0% 
Excision 20 13 65% 
Resection 48 4 8% 
Amputation 3 0 0% 
Cryosurgery 1 0 0% 
Total 129 46 37% 
 
Fig. (8). Distribution of desmoplastic fibroma in 266 patients. 
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in this case consisted of a hemipelvectomy and 
reconstruction using a cadaver hemipelvic allograft. As 
reported by Sanfilippo et al. and Nag et al. [18, 19] 
radiotherapy has also been shown to be a therapeutic option. 
Sanfiliippo et al. [19] treated one patient who had DF in the 
ilium with radiotherapy of 60 Gy in 30 fractions. Similarily, 
Nag et al. [18] treated one patient with DF in the distal end 
of the femur with radiotherapy of 45 Gy in 25 fractions. Both 
authors reported deceleration of disease progression over a 
time period of 30 and 36 months, respectively. Even though 
a decrease in pain sensations was achieved in both patients, 
radiotherapy did not lead to complete pain relief. 
 To date, 271 cases of DF, including the presented case 
have been published in the literature. Of these 270 cases, 30 
(11%) were localized in the pelvis and 15 (50%/ 5,5%) were 
localized in the ilium (Fig. 8). In 6 of the 15 ilium involved 
cases therapy was curettage, in 5 cases it was resection, in 1 
case radiotherapy was the definitive treatment [19], in 2 
cases the therapy is not known [20, 21] and in one case no 
operation or other treatment was performed [22]. In 2 of the 
15 cases a recurrence has been observed. These 2 patients 
were treated with curettage (Table 3). Compared to other 
regions where DF is common (e.g. mandible, humerus, 
femur) the treatment options in the ilium are more limited. 
Partial resection of the pelvis with subsequent reconstruction  
can lead to prolonged immobilization and persistence of pain 
[10]. Based on this review of the literature and on the 
experience with the presented case the authors recommend 
the following approach for the treatment of DF of the ilium: 
If no isolated extraosseus tumor growth is present and the 
stability of the pelvis is intact, curettage and grafting is a 
possible treatment modality. This modality should be offered 
to young and active patients, who comply with the 
requirement of yearly postoperative follow-up exams. In 
other cases resection and reconstruction seems to be the 
preferred treatment as it has a lower rate of recurrence. 
 Of note there seems to be a predilection for male patients 
being affected by DF in the ilium (male: 9, female: 2) while 
female patients seem to be more affected by DF in the jaw 
[23]. 
Table 3. Summary of Cases Reported About DF in the Ilium; NED: No Evidence of Recurrent Disease 
 
Reference Age/Gender Site Radiographic Pattern History Initial 
Treatment 
Follow-Up 
Period 
Comment 
22y/M Right Initial diagnosis: fibrous 
dysplasia 
2 months 
history of pain 
w/o hx of 
trauma 
wide local 
excision 
< 1y NED 
10y/M Right Initial diagnosis: 
Legg-Perthes disease 
3-4 months of 
pain w/o hx of 
trauma 
Curretage and 
graft 
7ys Recurrence, 
wide local 
excision 
Rabhan [24] 
24y/M Right Initial diagnosis: 
aneurysmal bone cyst 
4,5 years of 
pain in right 
groin 
Curretage and 
graft 
4ys Recurrence, 
second 
curretage and 
graft 
Whitesides [25] 8y/M Right initial diagnosis: 
aneurysmal bone cyst or 
hemingioma 
4 months of 
pain. Limp for 3 
weeks 
Curretage and 
graft 
21 months NED 
Nilsonne [26] 30y/F Right Initial diagnosis: 
metastasis of uterine 
cancer 
8 months of 
pain 
Curretage 12ys NED 
Stadler [27] 15y/M Left N/A Three weeks of 
pain 
Curretage N/A N/A 
Gebhardt [10] 28y/M Right N/A 6ys of 
intermittend 
pain and 
weakness 
Marginal 
resection with 
hemipelvic 
allograft 
5,5ys NED 
Goldman [28] 23y/M Right N/A 8 months of 
pain in right hip 
w/o trauma 
en bloc 
resection 
N/A N/A 
N/A N/A N/A N/A observation 11y slow 
progression Inwards [20] 
N/A N/A N/A N/A N/A N/A N/A 
Nishida [12] 35y/M Left Benign bone tumor N/A Curretage and 
graft 
9ys NED 
Zhang [29] 49y/F Right Benign bone tumor mild tenderness Wide resection N/A N/A 
Stefanidis [11] 56y/M Left Cortical breakthrough on 
CT-scan 
Lumbar pain. 
No hx of trauma 
Curettage and 
graft 
6ys NED 
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 In conclusion, the therapy of DF is strongly dependent on 
the region of the body that it affects and on the aggressive 
nature of the lesion. If a resection is feasible, as it is in the 
mostly affected bones (mandible and long bones), it should 
be performed, as resection has the lowest rate of recurrence 
[5]. In isolated intraosseus lesions without evidence of 
extension in adjacent soft tissue and when resection is 
associated with a higher risk because of anatomical 
conditions, a considerate risk-benefit-analysis should be 
carried out and thorough curettage may be an adequate 
management as it reduces operation time with a lower risk of 
infection and facilitates faster recovery. Once the decision 
has been made in accordance with the patient to perform a 
curettage, close postoperative observation, including clinical 
and radiographic examinations, is necessary to detect a 
recurrent lesion as early as possible. The higher risk of 
recurrence has to be well communicated with the patient 
preoperatively and has to be included in the decision finding 
process. 
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